Literature DB >> 22770733

Relative response factor determination of β-artemether degradants by a dry heat stress approach.

Bart M J De Spiegeleer1, Matthias D'Hondt, Elien Vangheluwe, Kirsten Vandercruyssen, Bart V I De Spiegeleer, Herwig Jansen, Ilse Koijen, Jacques Van Gompel.   

Abstract

During the stability evaluation of β-artemether containing finished drug products, a consistent and disproportional increase in the UV-peak areas of β-artemether degradation products, when compared to the peak area decline of β-artemether itself, was observed. This suggested that the response factors of the formed β-artemether degradants were significantly higher than β-artemether. Dry heat stressing of β-artemether powder, as a single compound, using different temperatures (125-150 °C), times (10-90 min) and environmental conditions (neutral, KMnO(4) and zinc), resulted in the formation of 17 degradants. The vast majority of degradants seen during the long-term and accelerated ICH stability study of the drug product, were also observed here. The obtained stress results allowed the calculation of the overall average relative response factor (RRF) of β-artemether degradants, i.e. 21.2, whereas the individual RRF values of the 9 most prominent selected degradants ranged from 4.9 to 42.4. Finally, Ames tests were performed on β-artemether as well as a representative stressed sample mixture, experimentally assessing their mutagenic properties. Both were found to be negative, suggesting no mutagenicity problems of the degradants at high concentrations. Our general approach and specific results solve the developmental quality issue of mass balance during stability studies and the related genotoxicity concerns of the key antimalarial drug β-artemether and its degradants.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22770733     DOI: 10.1016/j.jpba.2012.06.002

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  5 in total

1.  LC-UV/MS quality analytics of paediatric artemether formulations.

Authors:  Kirsten Vandercruyssen; Matthias D'Hondt; Valentijn Vergote; Herwig Jansen; Christian Burvenich; Bart De Spiegeleer
Journal:  J Pharm Anal       Date:  2013-04-25

2.  Stability study on an anti-cancer drug 4-(3,5-bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl)-4-oxo-2-butenoic acid (CLEFMA) using a stability-indicating HPLC method.

Authors:  Dhawal Raghuvanshi; Gregory Nkepang; Alamdar Hussain; Hooman Yari; Vibhudutta Awasthi
Journal:  J Pharm Anal       Date:  2016-09-28

3.  Selective separation, detection of zotepine and mass spectral characterization of degradants by LC-MS/MS/QTOF.

Authors:  M V N Kumar Talluri; Naveen Reddy Kandimalla; Raju Bandu; Divya Chundi; Ramesh Marupaka; Ragampeta Srinivas
Journal:  J Pharm Anal       Date:  2013-05-28

4.  A rapid stability-indicating, fused-core HPLC method for simultaneous determination of β-artemether and lumefantrine in anti-malarial fixed dose combination products.

Authors:  Sultan Suleman; Kirsten Vandercruyssen; Evelien Wynendaele; Matthias D'Hondt; Nathalie Bracke; Luc Duchateau; Christian Burvenich; Kathelijne Peremans; Bart De Spiegeleer
Journal:  Malar J       Date:  2013-04-30       Impact factor: 2.979

5.  Gas chromatographic method for the determination of lumefantrine in antimalarial finished pharmaceutical products.

Authors:  Sultan Suleman; Yannick Verheust; Ann Dumoulin; Evelien Wynendaele; Matthias D'Hondt; Kirsten Vandercruyssen; Lieselotte Veryser; Luc Duchateau; Bart De Spiegeleer
Journal:  J Food Drug Anal       Date:  2015-05-20       Impact factor: 6.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.